Day: January 8, 2026

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares of its common stock and pre-funded warrants to purchase 1,250,078 shares of common stock. The shares of common stock are being sold to the public at a price of $16.00 per share and the pre-funded warrants are being sold at a price of $15.999 per pre-funded warrant, which represents the per share price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Phathom from the offering, before deducting the underwriting discounts and commissions and other offering expenses,...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to provide an update in respect of its previously announced public offering (the “Offering”) of common shares of the Company (“Common Shares”) and/or pre-funded common share purchase warrants of the Company in lieu of Common Shares (“Pre-Funded Warrants” and, together with the Common Shares, the “Securities”). The Offering is being conducted on a commercially reasonable efforts agency basis for the...

MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (Nasdaq: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced the pricing of the underwritten public offering of 10,000,000 shares of common stock by certain of its existing stockholders at a price to the public of $20.50 per share. In addition, the underwriters of the offering have a 30-day option to purchase from the selling stockholders up to 1,500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The selling stockholders will receive all of the net proceeds from this offering. As part of the secondary offering, Jefferson Capital has agreed to concurrently purchase 3,000,000 shares of its common...

PASCAGOULA, Miss., Jan. 07, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) hosted John Phelan, secretary of the Navy, along with Adm. Daryl Caudle, chief of naval operations, and Gen. Eric Smith, commandant of the Marine Corps, at its Ingalls Shipbuilding division Wednesday. The senior leaders toured the shipyard, gained insights into HII’s workforce initiatives and discussed Ingalls’ role in delivering the U.S. Navy’s “Golden Fleet” of advanced surface combatants. “Ingalls Shipbuilding represents the ingenuity and commitment required to meet the Navy’s current and future needs. The shipbuilders I met today are on the front lines of American strength — men and women whose hard work protects our national security, underwrites our liberty, and sustains the way of life we are sworn to defend. There is no maritime dominance without their...

New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bleichroeder Acquisition Corp. II (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, January 8, 2026, under the ticker symbol “BBCQU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BBCQ” and “BBCQW,” respectively. The offering is expected to close on January 9, 2026, subject to customary closing conditions. The Company...

TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or the “Company”) today announced that Elliot Muchnik, Chief Financial Officer, is leaving the Company effective immediately to pursue other opportunities. “On behalf of illumin, I would like to thank Elliot for his service and contributions to the Company, and we wish him well in his future endeavors. As we move forward, our finance team will remain focused on execution and continuity,” said Simon Cairns, Chief Executive Officer. The Company may initiate a search process to assess potential internal and external candidates and expects to fill the permanent position of Chief Financial Officer in the coming months. In the interim, Michael Amaro has been appointed as Interim Chief Financial Officer. Mr. Amaro is a CPA and a seasoned...